Histone modification through acetylation and deacetylation is a key process in transcription, DNA replication, and chromosome segregation. During mitosis, histones are highly acetylated and chromatin is condensed. Here, we investigate the mechanistic involvement of histone deacetylase (HDAC) activity in the regulation of mitotic checkpoint activation. Inhibition of HDAC activity was found to cause the improper kinetochore localization of the mitotic checkpoint proteins, and to prolong mitotic arrest, and thus to lead to chromosomal instability due to aberrant exit from the mitotic cell cycle arrest. In addition, treatment with HDAC inhibitor attenuated the activations of p38 and ERK kinases, and increased the expression levels of cIAP-1, suggesting that the observed increased adaptation and chromosomal instability induced by inhibiting HDAC activity might be directly connected with the activations of cell survival and/or antiapoptotic signals. Moreover, the treatment of cells with mitotic defects with HDAC inhibitor increased their susceptibility to chromosomal instability. These results support the notion that HDAC activity plays an important role in the regulation of mitotic checkpoint activation, and thus the aberrant control of HDAC activity contributes to chromosomal instability.
Histone modification through acetylation and deacetylation is a key process in transcription, DNA replication, and chromosome segregation. During mitosis, histones are highly acetylated and chromatin is condensed. Here, we investigate the mechanistic involvement of histone deacetylase (HDAC) activity in the regulation of mitotic checkpoint activation. Inhibition of HDAC activity was found to cause the improper kinetochore localization of the mitotic checkpoint proteins, and to prolong mitotic arrest, and thus to lead to chromosomal instability due to aberrant exit from the mitotic cell cycle arrest. In addition, treatment with HDAC inhibitor attenuated the activations of p38 and ERK kinases, and increased the expression levels of cIAP-1, suggesting that the observed increased adaptation and chromosomal instability induced by inhibiting HDAC activity might be directly connected with the activations of cell survival and/or antiapoptotic signals. Moreover, the treatment of cells with mitotic defects with HDAC inhibitor increased their susceptibility to chromosomal instability. These results support the notion that HDAC activity plays an important role in the regulation of mitotic checkpoint activation, and thus the aberrant control of HDAC activity contributes to chromosomal instability. Oncogene (2003 Oncogene ( ) 22, 3853-3858. doi:10.1038 The cell cycle transition from interphase into mitosis requires several dramatic cellular events, which include chromosome condensation. Reversible chromosome condensation limits transcriptional machinery access to chromosomal DNA and inactivates chromatin remodeling complexes (Krebs et al., 2000) . A recent study showed that treatment of fission yeast with TSA, a specific inhibitor of histone deacetylases (HDACs), induced the hyperacetylated state in centromeric chromatin causing chromosome loss, and disruption of swi6p localization, a component of centromeric heterochromatin (Ekwall et al., 1997) . It has also been shown that the dynamic equilibrium between HAT and HDAC activities dramatically changes during mitosis and that the acetylated histones, gradually decreased during the early stages of mitosis, were absent in the metaphase and anaphase, and then gradually increased in the late mitotic phase (Kruhlak et al., 2001) . Thus, these results suggest that the regulation of acetylation may have a profound impact on both mitotic checkpoint surveillance and postmitotic progression regulation. The mechanisms by which acetylation and deacetylation influence the progression of the mitotic cell cycle, however, remain elusive.
Mitosis is a dramatic event and requires scrupulous care, because the segregation of duplicated chromosome pairs during the anaphase is irreversible. The mitotic checkpoint maintains the fidelity of this process by sensing proper microtubule attachment with the kinetochores and the tensions between the kinetochores of sister chromatids. Moreover, the mitotic checkpoint may activate signal cascades to delay the onset of anaphase until both kinetochores on each duplicated chromosome pair have successfully attached to the spindle microtubules and are under adequate tension, thus preventing the chromosome instability and polyploidy associated with cancer Rieder and Salmon, 1998; Amon, 1999; Wassmann and Benezra, 2000) . It is clear that the mitotic checkpoint plays a major role in generating the anaphase inhibitory signal; however, the mechanisms of chromosomal instability and polyploidy following release from the mitotic checkpoint are not well understood. Recently, it was found that human cancer cells with a chromosomal instability phenotype carried defects in their mitotic checkpoint, suggesting a possible link between impaired mitotic checkpoint and tumorigenesis (reviewed in Lengauer et al., 1998; Pihan and Doxsey, 1999) .
To examine the role of HDAC activity in the regulation of mitotic checkpoint activation, we treated synchronized HeLa cells with nocodazole and TSA, either singly or in combination, and harvested the cells at various time points for immunoblotting ( Figure 1a ) and flow cytometry (Figure 1b) . First, we monitored cyclin A and cyclin B stabilities, and the level of hBubR1 phosphorylation, as an indicator of mitotic checkpoint induction because the hyperphosphorylation of hBubR1 is known to be a prerequisite of exit from mitotic arrest (Taylor et al., 1998; Chan et al., 1999; Li et al., 1999) . In addition, it has been previously shown that cyclin A and cyclin B are degraded by activated anaphase-promoting complex (APC) during mitosis (Hunt et al., 1992; Sudakin et al., 2001) ; however, the degradation of cyclin A was found to occur before that of cyclin B by an as yet unidentified mechanism (Gorbsky, 1997; den Elzen and Pines, 2001; Geley et al., 2001 ). In particular, cyclin A is destabilized when cells enter mitosis and is almost completely degraded before the metaphase to anaphase transition (den Elzen and Pines, 2001; Geley et al., 2001) . Moreover, degradation of cyclin B is required for the transition from metaphase into anaphase (Gorbsky, 1997) . As shown in Figure 1a , the phosphorylation of hBubR1 was induced at 6 h, peaked at 24 h, and then decreased rapidly in cells treated with nocodazole alone. Figure 1 Inhibition of HDAC activity sustains mitotic arrest in response to mitotic checkpoint activation and increases chromosomal instability. HeLa cells were synchronized by serum starvation, released for 7 h, and then exposed to nocodazole (0.1 mg/ml) and TSA (100 nm), both separately and jointly. (a) At the indicated times, attached cells were harvested and lysed in TNN buffer (50 mm TrisHCl pH 7.4, 250 mm NaCl, 5 mm EDTA, 0.5% NP-40, 50 mm NaF, 1 mm DTT, 1 mm PMSF, 0.2 mm sodium orthovanadate, and protease inhibitor cocktail) for immunoblotting with anti-hBubR1, anti-cyclin A, anti-cyclin B, anti-HDAC1, anti-HDAC2, anti-HDAC3, anti-HDAC4, anti-HDAC7, anti-p53, and anti-actin antibodies. The polypeptide corresponding to each antibody is indicated on the right. Note that arrowhead represents the phosphorylated hBubR1. (b) Following treatment, cells were resuspended in cold PBS and fixed by the dropwise addition of cold 100% ethanol while gently vortexing; the cells were then stored at -201C. Fixed cells were washed in PBS, stained with propidium iodide (40 mg/ml), and treated with RNase A (50 mg/ml) for 30 min at room temperature. Samples of 10 000 cells were analysed for their DNA contents on a Becton Dickinson FACScan. The results shown are representative of four independent experiments Interestingly, the phosphorylation of hBubR1 was sustained over the entire time course in HeLa cells treated with both nocodazole and TSA. Moreover, cyclin A was dramatically destabilized in cells treated with nocodazole for 24 h; however, cyclin A was stable for up to 36 h in cells treated with nocodazole and TSA. In addition, the level of cyclin B rapidly decreased in cells treated with nocodazole for 30 h, but accumulated significantly in cells treated with both nocodazole and TSA ( Figure 1a ). However, we were unable to detect the apparent abundance changes of HDAC proteins during the same experimental condition. In addition, we obtained similar results in different human cell lines, i.e., MCF-7 and HCT 116 (data not shown). Taken together, HDAC inhibition was found to prolong the phosphorylation of hBubR1 and to block the degradations of cyclin A and cyclin B.
We next examined the consequence of the aberrant regulation of the mitotic checkpoint by HDAC inhibition. As shown in Figure 1b , the majority of cells treated with nocodazole were arrested at the mitotic (M) phase and in a relatively stable manner for up to 30 h. These arrested cells exhibited decreased hBubR1 hyperphosphorylation and cyclin B degradation. At 36 h after treatment with nocodazole, the percentage of cells arrested at the M phase decreased, and the population of sub-G1 (o2N) and polyploid (8N) cells slightly increased. In cells treated with TSA, the population of G1 cells significantly shifted to G2/M after 12 h. Subsequently, the equilibrium between G1/S and G2/ M populations was variable during incubation in the presence of TSA. However, we did not observe any significant apoptotic or polyploid cell population under this experimental condition. Interestingly, cells treated with both nocodazole and TSA exhibited dramatic changes in their DNA contents. In particular, the population of polyploid cells dramatically increased at 30-36 h (Figure 1b) . A high concentration (4500 nm) of TSA treatment in combination with nocodazole predominantly caused the apoptotic cell death (data not shown). However, the TSA concentration used for this study dominantly induced polyploidy and not apoptotic cell death. Several studies have implied that prolonged mitotic arrest induces aberrant exit from mitosis into G1, and progress through additional rounds of DNA replication, without cytokinesis and cell division, thus leading to polyploidy (Taylor and McKeon, 1997; Lengauer et al., 1998; Pihan and Doxsey, 1999) . Therefore, we propose that cells might aberrantly exit from prolonged mitotic arrest via the inhibition of HDAC activity in response to mitotic checkpoint activation, and thus become polyploid.
To investigate how TSA treatment induces the prolonged mitotic arrest, we monitored the subcellular distributions of kinetochore and HDAC proteins and chromosomal DNA structural abnormalities after inhibiting HDAC activity (Figure 2) . When HeLa cells were treated with nocodazole or TSA, hBubR1 protein was found to be exclusively localized in the cytoplasm of interphase cells or concentrated at the kinetochore in the later stages of the prophase and the prometaphase (Figure 2a) . However, we did not observe any abnormal distribution of hBubR1 protein at the kinetochores after TSA treatment. Interestingly, HeLa cells treated with both nocodazole and TSA showed that hBubR1 protein failed to be properly targeted to the kinetochores and was concentrated at only a few chromosomes. This result provides an important clue as to how TSA treatment, in response to mitotic checkpoint induction, prolongs mitotic arrest and increases chromosomal instability. It is widely believed that the kinetochore protein complexes of kinetochores unattached to a spindle signal induce cell cycle arrest at the metaphase (Amon, 1999; Wassmann and Benezra, 2000) . Therefore, the improper localization of kinetochore proteins during mitosis, as shown in Figure 2 , is probably sufficient to delay the anaphase inhibitory signal. Moreover, dramatic changes in chromatin condensation were also observed by DNA staining. In cells treated with both nocodazole and TSA, chromosomes were highly condensed throughout interphase to mitosis. However, TSA treatment did not induce any apparent changes in chromosome condensation.
We next examined the abundance of HDAC proteins at each stage of the cell cycle. In cells treated with TSA alone, HDAC1 protein destabilization was detected in the prophase. Surprisingly, after treatment with nocodazole and TSA, HDAC1 protein showed diffused staining even in the interphase, destabilization in the later stage of the prophase, and a slight redistribution throughout the prometaphase. We also observed similar results for HDAC2 and HDAC3 proteins (Figure 2b) . Furthermore, we monitored the localizations of different kinetochore proteins, namely CENP-C and Mad2, to compare their responses to the treatments with nocodazole and TSA. HeLa cells treated with both nocodazole and TSA showed improper distributions of CENP-C and Mad2 at the kinetochore ( Figure 2c) ; hBubR1 also abnormally targeted the kinetochore in these cells when arrested in mitosis. However, this improper pattern of localizations was not observed in cells treated with nocodazole or TSA. Thus, these results raise the possibility that the aberrant regulation of HDAC activity might influence the remodeling of mitotic chromatin, the biorientation of chromosomes, or the targeting of kinetochore proteins to chromosomes (thereby explaining that the inhibition of HDAC activity, in response to mitotic checkpoint activation, causes the improper localization of mitotic checkpoint protein at the kinetochore, triggering checkpoint protein signaling of cell cycle arrest at the metaphase and chromosomal instability).
It is noteworthy that both microtubule inhibitor and a specific inhibitor of HDACs are involved in mediating apoptosis. However, our results show that, in the presence of microtubule inhibitor, cells treated with a low concentration of TSA markedly prolong the mitotic cell cycle arrest and thus increase the population of polyploid cells instead of undergoing apoptosis. In normal conditions of prolonged mitotic arrest due to treatment with microtubule inhibitors such as nocodazole, or microtubule stabilizers such as taxol, cells mainly undergo mitotic cell cycle arrest and eventually apoptosis (Taylor and McKeon, 1997; Amon, 1999; Pihan and Doxsey, 1999) . However, inhibited HDAC activity might be correlated with the activation of survival/antiapoptotic signals, which overcome the apoptotic cell death triggered by prolonged mitotic arrest, and thus enable the generation of polyploidy (Minn et al., 1996) . Interestingly, recent studies have revealed that treatment with microtubule inhibitor activates kinases, such as p38 (Takenaka et al., 1998) , ERK (Lieu et al., 1998; Wang et al., 2000) , JNK (Amato et al., 1998) and p34 CDC2 (Shen et al., 1998) , and the microtubule inhibitor-induced activations of such kinases are associated with microtubule inhibitormediated apoptosis. In the present study, under the conditions used, combined treatment with nocodazole and TSA was found to increase the polyploidy, but to significantly reduce apoptosis compared to a single treatment of nocodazole (Figure 3a) . Analysis of MAPK activation showed that p38 phosphorylation appeared between 18 and 30 h after cells were treated with nocodazole. However, the phosphorylation of p38 was only evident at a single time point, that is, at 24 h, after combined TSA and nocodazole treatment (Figure 3b) . Similarly, ERK phosphorylation was increased 18 h after treatment with nocodazole and this was sustained for up to 36 h in the absence of TSA. However, the microtubule inhibitor-mediated phosphorylation of ERK was significantly reduced 30 h after treatment with TSA ( Figure 3b) . Thus, these results show a positive correlation between the fold activations of p38 and ERK kinases and the adaptation of cells to mitotic defect, which leads to chromosomal instability in conditions of HDAC inhibition. Furthermore, we monitored the expression levels of cIAP-1, an inhibitor of apoptosis protein. Interestingly, recent evidence has shown that the inactivation of cIAP-1 induces the premature onset of anaphase and thus increases poly- HeLa cells were treated with nocodazole (0.1 mg/ml) and TSA (100 nm), both separately and jointly, as described in Figure 1 . Cells were fixed in 5% formaldehyde for 10 min, washed, permeabilized in PBS containing 0.1% Triton X-100, and incubated in anti-mouse hBubR1, anti-rabbit HDAC1, anti-rabbit HDAC2, and anti-rabbit HDAC3 antibody. Subsequently, the cells were washed and further stained with Cy5-labeled anti-mouse (blue) or FITC-conjugated anti-rabbit (green) IgGs for 1 h. Cells were washed and exposed to propidium iodide to visualize the DNA (red). Cells at interphase (I), prophase (P), and prometaphase (PM) were digitally imaged by fluorescence microscopy (Zeiss). (c) Synchronized HeLa cells were treated and fixed as described above. Cells were stained with antihBubR1 antibody (green), anti-CENP-C antibody (red), anti-hMad2 antibody (green), and Hoechst dye to visualize the DNA (blue). Anti-CENP-C antibody was described previously (Saitoh et al., 1992) ploidy (Kallio et al., 2001) . At 30 h after treating HeLa cells with nocodazole, the expression of cIAP-1 was significantly reduced, whereas treating with TSA in combination with nocodazole produced no apparent change in cIAP-1 expression over the entire time course (Figure 3b ). These results suggest that when HDAC is inhibited, cells activate antiapoptotic signals, which bypass prolonged mitotic arrest, and lead to increased polyploidy. However, the actual signaling cascade by which the HDAC inhibition reduces p38 and ERK activations and blocks cIAP-1 reduction remains to be elucidated. Overall, HDAC inhibition in response to mitotic checkpoint activation contributes to chromosomal instability not only through improper kinetochore protein localization but also through the activations of the survival/antiapoptotic signal pathways. A variety of evidence suggests that many human cancer cells are adapted to manage such mitotic defects, and that persisting mitotic defects are likely to contribute to tumorigenesis due to abnormal chromosome segregation or to failures in mitotic checkpoint activation (Cahill et al., 1999; Pihan and Doxsey, 1999; Wassmann and Benezra, 2000) . The fidelity of a defective mitotic checkpoint in vivo can be elucidated by investigating mutations in mitotic regulators such as, mitotic checkpoint genes, Bub1 and BubR1/Mad3 Pihan and Doxsey, 1999) . Here, we were interested in observing whether the employment of HDAC inhibitors in cells with mitotic defects influences polyploidy following the mitotic checkpoint. We have established that HeLa cells expressing the dominant-negative mutant of the mitotic checkpoint protein hBub1 (HeLa-N-hBub1) to mimic the in vivo conditions of mitotic defect. The mutant hBub1 protein, which contains the kinetochore localization domain (amino acids 1-331) without the carboxy-terminal kinase domain, acted as a dominant-negative version, as was demonstrated for mouse Bub1 protein (data not shown; Taylor and McKeon, 1997) . In the present study, HeLa and HeLa-N-hBub1 cells were synchronized, treated with nocodazole and TSA, both separately and jointly, and then analysed by flow cytometry Figure 4 , upper panel). In comparison to the parental HeLa cells, HeLa-N-hBub1 cells exhibited a delay in the accumulation of an apoptotic cell population and an increment in the polyploid population, when treated continuously with nocodazole alone, which is consistent with a previous report (Taylor and McKeon, 1997) . Interestingly, treatment with TSA alone did not cause any apparent change in the apoptotic population (Figure 4 , upper panel). However, under the conditions used, the apoptotic cell populations in HeLa and HeLa-N-hBub1 cell lines, previously treated with nocodazole and TSA in combination, were apparently no different versus those treated with nocodazole alone (Figure 4 , upper panel). Both cell lines showed a dramatic increase of polyploid population after treatment (Figure 4 , lower panel). Interestingly, HeLa-N-hBub1 cells showed a higher accumulation of polyploid cells after combined TSA and nocodazole treatment than the parental HeLa cells. These results suggest that cells with defective mitotic checkpoint increase the susceptibility of chromosomal instability by inhibiting HDAC activity.
In conclusion, this study demonstrates that HDAC inhibition prolongs mitotic arrest, probably by the improper kinetochore localization of mitotic checkpoint proteins, and that cells then aberrantly exit from this arrest and this leads to increased chromosomal instability without significant apoptotic cell death. Interestingly, HDAC inhibition apparently induced cell survival and/or antiapoptotic signaling in response to the mitotic checkpoint. Furthermore, we also found that HDAC inhibitor augments the formation of polyploidy in cells with a mitotic defect, suggesting that HDAC activity is involved in the regulation of the mitotic checkpoint.
